Tumour microenvironment responsive nanoconstructs for cancer theranostic
- Publication Type:
- Journal Article
- Nano Today, 2019, 26 pp. 16 - 56
- Issue Date:
|1-s2.0-S1748013218305346-main.pdf||Published Version||14.77 MB|
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
© 2019 Elsevier Ltd The tumour mass is made up of not only of a heterogeneous population of cancer cells nonetheless also a mixture of resident as well as the infiltrating host cells, secreted factors besides extracellular matrix proteins, together recognized as the tumour microenvironment (TME). Tumour development is overwhelmingly affected through the dealings of cancer cells with their environment which eventually conclude whether the primary tumour is eliminated, metastasizes or creates dormant micro metastases. The TME may perhaps shape therapeutic responses as well as resistance. Some inimitable features of TME, for example vascular abnormalities, hypoxia, acidic pH and glutathione (GSH) are comparative to normal tissue. Several types of cells, together with tumour cells, macrophages, immune and fibroblast cells are nourished by flawed blood vessels in the solid tumour. To dispense anticancer agents to tumour sites nanovehicles can be competent carts. For augmented therapeutic efficacy, TME is the key for designing of nanoparticles (NPs). In this review, we will discuss the TME and summarize the current advancement in several nano-formulations for cancer therapy, with an extraordinary stress on TME-responsive ones. Scheme 1 highlights several TME modulation tactics with positive cancer therapeutic competence. The design of nanoconstructs and future challenges, consideration and opportunities are also discussed in detail. We have confidence in that these modulation approaches of TME tender a reliable opportunity for the practical translation of nanoparticle formulas into clinic.
Please use this identifier to cite or link to this item: